Related references
Note: Only part of the references are listed.Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy
Claudio Bellevicine et al.
CANCER CYTOPATHOLOGY (2020)
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma
Kyeong J. Kim et al.
EUROPEAN JOURNAL OF CANCER (2020)
Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification
Giovanni Tallini et al.
CANCERS (2020)
Is papillary thyroid microcarcinoma a biologically different disease? A propensity score-matched analysis
Yi-Chiung Hsu et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia
Kanakamani Jeyaraman et al.
BMC ENDOCRINE DISORDERS (2019)
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations
Claudio Bellevicine et al.
CANCER CYTOPATHOLOGY (2018)
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials
Y. Ito et al.
EJSO (2018)
Thyroid cancer phenotypes in relation to inflammation and autoimmunity
Loredana Pagano et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea
Mijin Kim et al.
THYROID (2018)
BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report
Elisabetta Macerola et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2017)
Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany
Markus Eszlinger et al.
THYROID (2017)
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality
Rengyun Liu et al.
JAMA ONCOLOGY (2017)
The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications
Ana Cunha Rodrigues et al.
CURRENT GENOMICS (2017)
How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings?
Loredana Pagano et al.
ENDOCRINE (2017)
BRAFV600E Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis
Yufei Chen et al.
THYROID (2016)
Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAFK601E Mutation
Michelle Afkhami et al.
THYROID (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis
Fei Li et al.
ENDOCRINE-RELATED CANCER (2015)
BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma
Andre Uchimura Bastos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma
Greta Gandolfi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study
Giovanni Tallini et al.
MODERN PATHOLOGY (2015)
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas
Dario de Biase et al.
THYROID (2015)
Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma
Yinlong Yang et al.
CLINICAL ENDOCRINOLOGY (2014)
TERT Promoter Mutations and Their Association with BRAF V600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer
Xiaoli Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
Miguel Melo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
BRAFV600E in Papillary Thyroid Carcinoma Is Associated with Increased Programmed Death Ligand 1 Expression and Suppressive Immune Cell Infiltration
Trevor E. Angell et al.
THYROID (2014)
Papillary Microcarcinoma of the Thyroid: Clinical Characteristics and BRAFV600E Mutational Status of 977 Cases
Xiangqian Zheng et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma
Esther Diana Rossi et al.
CANCER CYTOPATHOLOGY (2013)
Aggressive Papillary Thyroid Microcarcinoma Prognostic Factors and Therapeutic Strategy
Guglielmo Ardito et al.
CLINICAL NUCLEAR MEDICINE (2013)
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Xiaoli Liu et al.
ENDOCRINE-RELATED CANCER (2013)
BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation
Renu K. Virk et al.
MODERN PATHOLOGY (2013)
Tall Cell Variant of Papillary Thyroid Microcarcinoma: Clinicopathologic Features with BRAFV600E Mutational Analysis
Jane Bernstein et al.
THYROID (2013)
Clinicopathologic Implications of the BRAFV600E Mutation in Papillary Thyroid Cancer: A Subgroup Analysis of 3130 Cases in a Single Center
Jae Yun Lim et al.
THYROID (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
BRAFV600E mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness
Neslihan Kurtulmus et al.
ENDOCRINE (2012)
The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma
Kuai-Lu Lin et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases
Fulvio Basolo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma
Xiaolong Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
BRAF(V600E) mutation and the biology of papillary thyroid cancer
F. Frasca et al.
ENDOCRINE-RELATED CANCER (2008)
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
Ian D. Hay et al.
SURGERY (2008)
Extensive clinical experience - Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma
Cristiana Lupi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
BRAFV600E mutation and p27kip1 expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases
Vito Rodolico et al.
CANCER (2007)
Presence of BRAF V600E in very early stages of papillary thyroid carcinoma
Clara Ugolini et al.
THYROID (2007)
Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization
R Corvi et al.
LABORATORY INVESTIGATION (2001)
Share Paper
